Am J Perinatol 2018; 35(01): 016-023
DOI: 10.1055/s-0037-1603991
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prenatal Maternal Hyperoxygenation Testing and Implications for Critical Care Delivery Planning among Fetuses with Congenital Heart Disease: Early Experience

David N. Schidlow
1   Children's National Heart Institute, Children's National Health System, Washington, District of Columbia
2   Department of Pediatrics (Cardiology), George Washington University School of Medicine and Health Sciences, Washington, District of Columbia
,
Mary T. Donofrio
1   Children's National Heart Institute, Children's National Health System, Washington, District of Columbia
2   Department of Pediatrics (Cardiology), George Washington University School of Medicine and Health Sciences, Washington, District of Columbia
› Author Affiliations
Further Information

Publication History

22 February 2017

25 May 2017

Publication Date:
26 July 2017 (online)

Abstract

Background Maternal hyperoxygenation (MH) during fetal ultrasound can characterize fetal pulmonary vasoreactivity (PVr) and its associations with postnatal physiology.

Objective We explored MH testing to facilitate perinatal risk stratification for fetuses with congenital heart disease (CHD).

Methods MH was performed in 12 fetuses: 2 with Ebstein anomaly, 2 with total anomalous pulmonary venous connection (TAPVC), 4 with hypoplastic left heart syndrome (HLHS) with (a) restrictive atrial septum (RAS) or (b) intact atrial septum (IAS) with decompressing vertical vein (VV), and 4 with D-loop transposition of the great arteries (TGA). PVr and physiologic and anatomic changes with MH and outcomes were recorded.

Results Among Ebstein fetuses, pulmonary blood flow with MH mirrored postnatal findings. Among TAPVC fetuses, MH VV gradients correlated with postnatal gradients. One HLHS/IAS/VV fetus had no PVr and decreased pulmonary vein forward to reverse velocity time integral ratio with MH. Shortly after delivery, the infant experienced severe low cardiac output and required urgent atrial septoplasty. The remaining HLHS fetuses had PVr and underwent routine Stage 1 Norwood. Among TGA fetuses, septum primum position, foramen ovale flow, and the presence or absence of PVr with MH reflected postnatal findings.

Conclusion MH may help identify fetuses with CHD at risk for perinatal compromise. Additional study may yield insights into fetal PVr and elucidate predictors of perinatal outcomes.

Funding

None.


 
  • References

  • 1 Escobar-Diaz MC, Freud LR, Bueno A. , et al. Prenatal diagnosis of transposition of the great arteries over a 20-year period: improved but imperfect. Ultrasound Obstet Gynecol 2015; 45 (06) 678-682
  • 2 Donofrio MT, Levy RJ, Schuette JJ. , et al. Specialized delivery room planning for fetuses with critical congenital heart disease. Am J Cardiol 2013; 111 (05) 737-747
  • 3 Donofrio MT, Moon-Grady AJ, Hornberger LK. , et al; American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129 (21) 2183-2242
  • 4 Donofrio MT, Skurow-Todd K, Berger JT. , et al. Risk-stratified postnatal care of newborns with congenital heart disease determined by fetal echocardiography. J Am Soc Echocardiogr 2015; 28 (11) 1339-1349
  • 5 Olivieri L, Ratnayaka K, Levy RJ, Berger J, Wessel D, Donofrio M. Hypoplastic left heart syndrome with intact atrial septum sequelae of left atrial hypertension in utero. J Am Coll Cardiol 2011; 57 (20) e369
  • 6 Glatz JA, Tabbutt S, Gaynor JW. , et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007; 84 (05) 1633-1638
  • 7 Punn R, Silverman NH. Fetal predictors of urgent balloon atrial septostomy in neonates with complete transposition. J Am Soc Echocardiogr 2011; 24 (04) 425-430
  • 8 Jouannic JM, Gavard L, Fermont L. , et al. Sensitivity and specificity of prenatal features of physiological shunts to predict neonatal clinical status in transposition of the great arteries. Circulation 2004; 110 (13) 1743-1746
  • 9 Bartlett JM, Wypij D, Bellinger DC. , et al. Effect of prenatal diagnosis on outcomes in D-transposition of the great arteries. Pediatrics 2004; 113 (04) e335-e340
  • 10 Maeno YV, Kamenir SA, Sinclair B, van der Velde ME, Smallhorn JF, Hornberger LK. Prenatal features of ductus arteriosus constriction and restrictive foramen ovale in d-transposition of the great arteries. Circulation 1999; 99: 1209-1215
  • 11 Broth RE, Wood DC, Rasanen J. , et al. Prenatal prediction of lethal pulmonary hypoplasia: the hyperoxygenation test for pulmonary artery reactivity. Am J Obstet Gynecol 2002; 187 (04) 940-945
  • 12 Channing A, Szwast A, Natarajan S, Degenhardt K, Tian Z, Rychik J. Maternal hyperoxygenation improves left heart filling in fetuses with atrial septal aneurysm causing impediment to left ventricular inflow. Ultrasound Obstet Gynecol 2015; 45 (06) 664-669
  • 13 DeKoninck P, Lewi P, Done E. , et al. Sonographic evaluation of vascular pulmonary reactivity following oxygen administration in fetuses with normal lung development. Prenat Diagn 2012; 32 (13) 1300-1304
  • 14 Szwast A, Tian Z, McCann M, Donaghue D, Rychik J. Vasoreactive response to maternal hyperoxygenation in the fetus with hypoplastic left heart syndrome. Circ Cardiovasc Imaging 2010; 3 (02) 172-178
  • 15 Michelfelder E, Gomez C, Border W, Gottliebson W, Franklin C. Predictive value of fetal pulmonary venous flow patterns in identifying the need for atrial septoplasty in the newborn with hypoplastic left ventricle. Circulation 2005; 112 (19) 2974-2979
  • 16 Divanović A, Hor K, Cnota J, Hirsch R, Kinsel-Ziter M, Michelfelder E. Prediction and perinatal management of severely restrictive atrial septum in fetuses with critical left heart obstruction: clinical experience using pulmonary venous Doppler analysis. J Thorac Cardiovasc Surg 2011; 141 (04) 988-994